⌕
Artivion · AORT · NYSE
Tenet 37 · Weak
Compare
$18.27−1.08%At closeTenet 37 · Weak
$18.27−0.20 (−1.08%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Artivion (AORT) Stock

Artivion (AORT) closed at $18.27 on Nov 17, 2026; its Tenet Score is 37 of 100 against 340 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

9 figures withheld by our checks. Each blank figure names its reason.

Key stats

Close
$18.27
Nov 17, 2026
Market cap
$901.1M
share price × the latest quarter's diluted weighted-average share count (vendor)
52-week range
18.11 – 48.25
low → high · as of close, Nov 16, 2026
Tenet Score
37/100
Weak · 340 Healthcare peers

Industry: Health Services

Artivion Inc scores 37/100. Weak. Financial health is the soft spot versus 340 Healthcare peers.

Tenet Score · vs sector

n=340
37/ 100
Weak
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
37
Quality
48
Health
27
Growth
36

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueDQualityDHealthFGrowthDMomentumF
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/E
—
Not meaningful: the company made a loss.
P/B
2.0×
Sep 30, 2026 balance sheet
P/S
1.9×
price to sales, TTM through Sep 30, 2026 · as of close, Nov 16, 2026
ROE
−4%
TTM through Sep 30, 2026
Operating margin
7.6%
fiscal 2025, before interest and tax
Net margin
−3.7%
TTM through Sep 30, 2026
Current ratio
4.42
Sep 30, 2026 balance sheet
Net debt / EBITDA
8.5×
TTM through Sep 30, 2026
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
Not applicable: the company pays no regular dividend.

The whole report, at a glance · every card is a live peek, click any to open the section

About Artivion Inc

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologi…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=340) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 82 US ETFs · top wrappers by weightSee all ETFs holding AORT →

Similar-sized companies in Health Services

The 10 companies in this industry closest in market cap, as of Nov 16, 2026.

What sector and industry is Artivion in?

Artivion is in the Healthcare sector and the Health Services industry.

What is Artivion's Tenet Score?

Artivion's Tenet Score is 37 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.